Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study of Intravenous (IV) TKM-100201 Infusion

This study has been terminated.
(Corporate decision to reformulate the investigational product.)
Sponsor:
Collaborator:
United States Department of Defense
Information provided by (Responsible Party):
Arbutus Biopharma Corporation
ClinicalTrials.gov Identifier:
NCT01518881
First received: November 8, 2011
Last updated: January 8, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2012
  Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)